Chester County News and Community Website
YARDLEY, PA — Optinose (NASDAQ: OPTN) has announced its financial results for the year and quarter ending December 31, 2024, spotlighting strong growth in XHANCE prescriptions and revenue. The company also …
Optinose Reports 2024 Financial Results, Highlights Prescription Growth and First Operational Income Read More
NEWARK, DE — Artesian Resources Corporation (Nasdaq: ARTNA) has announced its financial results for 2024, reporting robust earnings growth alongside significant investments in water and wastewater infrastructure.
Artesian Resources Reports Strong 2024 Financial Performance and Investments in Infrastructure Read More
LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) has announced its fourth-quarter and full-year 2024 financial results, highlighting unprecedented growth in revenue, gross profit, and operational milestones.
NEXGEL Reports Record-Breaking 2024 Financial Performance Read More
BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) has announced significant progress in its nomlabofusp program for Friedreich’s Ataxia (FA), reporting key regulatory advancements, ongoing clinical developments, and a robust …
Larimar Therapeutics Advances Nomlabofusp Program Amid Regulatory Support Read More
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE), a clinical-stage biopharmaceutical company, shared its financial results for 2024 and provided a progress update on its lead programs aimed at advancing cancer …
Aprea Therapeutics Reports 2024 Financial Results and Updates on Clinical Innovations Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has shared its corporate updates and financial results for the fourth quarter and full year of 2024, highlighting significant advancements in its clinical …
Annovis Bio Reports Progress in Clinical Trials and Improved Financial Position Read More
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) has reported its financial results for the year ending December 31, 2024, while highlighting advancements in its clinical pipeline.
Context Therapeutics Reports 2024 Results and Outlines Clinical Advancements Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has reported its financial results for the fourth quarter and full year 2024. The company showcased a year of steady growth and operational …
TELA Bio Announces 2024 Financial Results and Positive 2025 Outlook Read More
PHILADELPHIA, PA — Five Below, Inc. (NASDAQ: FIVE) reported its financial results for the fourth quarter and full year of fiscal 2024, showcasing steady growth despite a challenging retail environment. The …
Five Below Reports Fiscal 2024 Results and Outlines Growth Plans for 2025 Read More
PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) outlined a strategic pipeline re-prioritization and shared its financial results for the year 2024. This move aims to focus on potentially groundbreaking programs …
Century Therapeutics Announces Strategic Pipeline Shift and 2024 Financial Results Read More